highly significantP <0.001
The presence of PTEN gene loss in the absence of ERG/ETV1 gene rearrangements identified a patient population (6%) with poorer cancer-specific survival that was highly significant (HR=4.87, P <0.001 in multivariate analysis, 13.7% survival at 11 years) when compared with the ‘good prognosis’ group.